Browse Inside eLife

Page 11 of 84
  1. eLife Latest: A new vision for transforming research communication

    eLife’s plans for the future encompass our core values of openness, integrity and inclusiveness.
  2. eLife Latest: Applications open for new Reviewing Editors from Latin America and the Caribbean

    eLife is looking to recruit researchers from these regions with an open call for self-nominations to its editorial board.
  3. For Authors: Why publish with eLife?

    eLife is committed to publishing high-quality research in all areas of biology and medicine, and to reforming peer review and publishing.
  4. Call for Pitches: “When things don’t go to plan”

    Tell us about what went wrong – and what came next.
  5. Peer Review: Highlighting preprints reviewed by eLife during February

    Read what peer reviewers thought about three recent preprints on the links between heart disease and breast cancer, proton pumps and malaria, and the response of neurons to mechanical forces.
  6. eLife Community: Launching the Open Science Champions network

    This new network aims to support researchers to learn and encourage open science practices.
    1. Neuroscience
    2. Immunology and Inflammation

    Event Report: Neuroimmunology Symposium

    Catch up on our recent symposium – “from evolution to function in health and disease”.
  7. eLife Latest: January 2022 update on our actions to promote equity, diversity and inclusion

    This third report on our work to address inequities in research and publishing shares our recent progress and plans for the first half of the year ahead.
  8. eLife Community Ambassadors: Welcoming 128 researchers to the programme

    Advocates of responsible science practises representing over 50 countries join the eLife Community Ambassadors programme to learn from each other and create change across the global research community.
  9. Event Report: Evolutionary Medicine Symposium

    eLife authors showcase their research from the Evolutionary Medicine Special Issue – watch now.